Author(s):
Pruthvi Patel, Swapnil Parmar, Srushti Christi, Kinjal Chunara, Musaratafrin Saiyed, Sunilkumar Karna
Email(s):
musaratsaiyed40@gmail.com
DOI:
10.52711/2321-5836.2026.00016 
Address:
Pruthvi Patel1, Swapnil Parmar1, Srushti Christi1, Kinjal Chunara1, Musaratafrin Saiyed2*, Sunilkumar Karna3
1Student, Department of Pharmacology, A.R. College of Pharmacy and G.H. Patel Institute of Pharmacy, Vallabh Vidyanagar, Anand, Gujarat, India.
2Assistant Professor, Department of Pharmacology, A.R. College of Pharmacy and G. H. Patel Institute of Pharmacy, Vallabh Vidyanagar, Anand, Gujarat, India.
3Interventional Cardiologist, B M Patel Cardiac Centre, Shree Krishna Hospital, Karamsad, Anand, Gujarat.
*Corresponding Author
Published In:
Volume - 18,
Issue - 2,
Year - 2026
ABSTRACT:
Objective: Prescription pattern monitoring studies (PPMS) are crucial for evaluating medication use, particularly in managing cardiovascular diseases like hypertension and ischemic heart disease. This study examined the prescribing patterns of cardiovascular drugs in a rural tertiary care hospital's cardiology OPD, according to WHO core prescribing indicators. Methodology: An observational, hospital-based study was conducted over three months, with approval from the Institutional Ethics Committee. The study evaluated prescriptions for commonly prescribed cardiovascular drugs, focusing on CVD alone, CVD with comorbidities and CVD with other conditions. A number of drugs prescribed by generic versus brand name, monotherapy versus combination therapy, and the essentiality of drugs based on the Essential Drugs List (EDL) and National List of Essential Medicines (NLEM) were evaluated. Microsoft Excel was used for data analysis. Results and Discussion: A total of 176 prescriptions containing 97 different drugs were evaluated. Of these, 24.48% were for patients with CVD alone, 27.79% for CVD with comorbidities and 47.63% for CVD with other conditions. Generic drugs were prescribed in 62.43% of cases. Antiplatelets, sympatholytics, diuretics, and RAAS blockers were the most commonly prescribed drugs. Among 176 prescriptions consisted of 97 drugs, the majority of them prescribed as monotherapy and then a Two-drug regimen and found Essential according to EDL 42.27% and NLEM 39.18%. Conclusion: This study highlights the importance of a comprehensive approach to managing CVD and related conditions, highlighting the preference for generic medications to enhance accessibility and affordability, personalized patient care and the careful selection of medications to maximize therapeutic benefits while minimizing risks.
Cite this article:
Pruthvi Patel, Swapnil Parmar, Srushti Christi, Kinjal Chunara, Musaratafrin Saiyed, Sunilkumar Karna. Patterns of Cardiovascular Drug Prescriptions in a Rural Tertiary Care Hospital: Insights from the Cardiology Outpatient Department in Anand. Research Journal of Pharmacology and Pharmacodynamics.2026;18(2):117-6. doi: 10.52711/2321-5836.2026.00016
Cite(Electronic):
Pruthvi Patel, Swapnil Parmar, Srushti Christi, Kinjal Chunara, Musaratafrin Saiyed, Sunilkumar Karna. Patterns of Cardiovascular Drug Prescriptions in a Rural Tertiary Care Hospital: Insights from the Cardiology Outpatient Department in Anand. Research Journal of Pharmacology and Pharmacodynamics.2026;18(2):117-6. doi: 10.52711/2321-5836.2026.00016 Available on: https://rjppd.org/AbstractView.aspx?PID=2026-18-2-1
REFERENCES:
1. Pavani V, Cidda M, Nalini M, Krishna TR, Parmar MY, et al. Study of prescribing patterns of common health problems. Int J Pharm Biol Sci. 2012; 2(4): 22–31.
2. World Health Organization. Cardiovascular diseases [Internet]. Available from: https://www.who.int/news-room/fact-sheets/detail/ cardiovascular-diseases-(cvds). Accessed January 2024.
3. Roy A, Patel NK, et al. Prescribing patterns of cardiovascular drugs in cardiology outpatient department in a tertiary care hospital in Western Odisha. Int J Basic Clin Pharmacol. 2021; 10(1): 23–28.
4. Jyothsna CS, Nagarajaiah BH, Shivakumar KM, et al. Drug utilization pattern in geriatric inpatients of medicine wards at a government tertiary care hospital. Natl J Physiol Pharm Pharmacol. 2019; 9(4): 320–327.
5. World Health Organization Western Pacific Regional Office. Essential medicines WPRO [Internet]. Available from: https://www.who.int/westernpacific/health-topics/essential-medicines. Accessed February 2024.
6. Rabie D, Kheder SI, et al. Assessment of prescribing and dispensing practices based on WHO core prescribing indicators in hospital and community pharmacies in Khartoum State, Sudan. J Med Inform Decis Mak. 2020; 1(3): 1–11.
7. Rao A, Kumar KS, Rai M. Prescription pattern in patients having heart failure in a south Indian tertiary care hospital: A retrospective study. Indian J Pharm Pharmacol. 2017; 4(3): 114–119.
8. Rabie D, Kheder SI. Assessment of prescribing and dispensing practices based on WHO core prescribing indicators in hospital and community pharmacies in Khartoum State. JMID. 2020; 1(3): 1–9.
9. Tripathi KD. Essentials of Medical Pharmacology. 5th ed. New Delhi: Jaypee Brothers Medical Publishers; 2005.
10. Shanbhag TV. Pharmacology for Medical Graduates. 4th ed. New Delhi: Elsevier; 2020.
11. Mukadam FM, Gawali UP, Chavarkar P, Ali DP, Naghotkar S. Prescription patterns of drugs used in patients with coronary artery disease at tertiary care hospital. J Pharm Care. 2022; 10(3): 98–102.
12. Morris J, Awosika AO, Dunham A. Metoprolol [Internet]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532923/. Accessed February 2024.
13. Weber MA. The role of the new β-blockers in treating cardiovascular disease. Am J Hypertens. 2005; 18(6): 169–176.
14. Osuafor NG, Ukwe CV, Okonta MJ. Prescription pattern of cardiovascular and/or antidiabetic drugs in Abuja district hospitals. Int J Pharm Pharm Sci. 2019; 11(9): 21–25.
15. Thomas BR, Catherin TJ, Sabu N, ES L, Baby N, Menaka K, et al. Prescribing pattern of cardiovascular drugs: A prospective observational study. Indian J Pharm Pract. 2017; 10(4): 287–291.
16. Nicolas D, Kerndt CC, Patel P, et al. Sacubitril-Valsartan [Internet]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507904/. Accessed April 2024.
17. DrugBank. Isosorbide mononitrate [Internet]. Available from: https://go.drugbank.com/drugs/DB01020. Accessed April 2024.
18. Domino FJ, Baldor RA. The 5-Minute Clinical Consult. 30th ed. Philadelphia: Wolters Kluwer; 2022.
19. PubChem. Sitagliptin. PubChem compound summary for CID 4369359 [Internet]. Bethesda (MD): National Library of Medicine (US); Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Sitagliptin. Accessed April 2024.
20. Wu H, Yuan G, Han Y, Yan Y, Li G, Zhao C, et al. Glimepiride use is associated with reduced cardiovascular mortality in patients with type 2 diabetes and chronic heart failure: A prospective cohort study. Eur J Prev Cardiol. 2023; 30(6): 474–487.
21. Medicover Hospitals. What is voglibose [Internet]. Available from: https://www.medicoverhospitals.in/medicine/voglibose. Accessed April 2024.
22. Rabbany MMA, Saha BKS, Subha N, Sultana I, Islam MS, Hossain AJ, et al. Comparative efficacy of levosalbutamol and racemic salbutamol in the treatment of acute exacerbation of asthma. Mymensingh Med J. 2023; 32(1): 10–17.
23. Pozzi E. Acebrophylline: An airway mucoregulator and anti-inflammatory agent. Monaldi Arch Chest Dis. 2007; 67(2): 106–115.
24. MyActiveHealth. Anticholinergics for chronic obstructive pulmonary disease (COPD) [Internet]. Available from: https://www.myactivehealth.com/hwcontent/content/drugdetail/hw165152.html. Accessed April 2024.
25. Heredia JL. Tiotropium bromide: An update. Open Respir Med J. 2009; 3:43–52.
26. Apollo Pharmacy. About levosalbutamol [Internet]. Available from: https://www.apollopharmacy.in/salt/LEVOSALBUTAMOL. Accessed April 2024.
27. Townley RG, Suliaman F. The mechanism of corticosteroids in treating asthma. Ann Allergy. 1987;58(1):1–6.
28. DrugBank. Theophylline [Internet]. Available from: https://go.drugbank.com/drugs/DB00277. Accessed April 2024.
29. U.S. Food and Drug Administration. Montelukast sodium [Internet]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020829s051_020830s052_021409s028lbl.pdf. Accessed April 2024.
30. Pelkonen AS, Malmström K. The effect of montelukast on respiratory symptoms and lung function in wheezy infants. Eur Respir J. 2013; 41: 664–670.
31. HealthCentral. Is your thyroid medication working? [Internet]. Available from: https://www.healthcentral.com/condition/hypothyroidism/signs-your-thyroid-medication-is-working. Accessed April 2024.
32. Zaman MA, Awais N, Satnarine T, Ahmed A, Haq A, Patel D, et al. Comparing triple combination drug therapy and traditional monotherapy for better survival in patients with high-risk hypertension: A systematic review. Cureus. 2023; 15(7): e4139.